Skip to content

Organogenesis Holdings Inc. ORGO Accretion To Redemption Value And Cumulative Dividends On Redeemable Convertible Preferred Stock

Accretion To Redemption Value And Cumulative Dividends On Redeemable Convertible Preferred Stock at other companies

Ondas, Inc.
 logo
Ondas, Inc. ONDS
-$727K
Westrock Coffee Company logo
Westrock Coffee CompanyWEST
-$86K0.0%
Hagerty logo
HagertyHGTY
$2.03M+8.3%
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
$0
FIP
FTAI Infrastructure Inc.FIP
$0+100%
CG Oncology logo
CG OncologyCGON
$0

Other financials

Income statement

See full
Revenue$37.2M-57.1%
Gross profit$63.0M-22.5%
Operating income-$68.9M-158%
Net income-$53.2M-182%
EPS (diluted)-$0.44-159%

Balance sheet

See full
Cash & equivalents$91.4M-16.9%
Total debt$39.4M+24.8%
Total equity$244.6M+0.7%
Total assets$520.0M+11.3%

Cash flow

See full
Operating cash flow$21.1M+206%
CapEx$3.1M-13.2%
Free cash flow$18.0M+176%

Valuation

See full
Market cap$312.68M-23.7%
Enterprise value$260.72M-21.3%
P/E115×
P/S0.6×-0.3×

Profitability

See full
Gross margin75.9%+0.8pp
Operating margin0.5%
Net margin0.5%+0.3pp
FCF margin6.9%

Returns & leverage

See full
Return on equity1.1%+0.6pp
Debt / equity0.2×0.0×
Current ratio3.5×-0.6×

Where this comes from

Reported directly by Organogenesis Holdings Inc. in its filing.

Tagged under the XBRL concept orgo:AccretionToRedemptionValueAndCumulativeDividendsOnRedeemableConvertiblePreferredStock.

The official record: Organogenesis Holdings Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organogenesis Holdings Inc.'s accretion to redemption value and cumulative dividends on redeemable convertible preferred stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organogenesis Holdings Inc.'s accretion to redemption value and cumulative dividends on redeemable convertible preferred stock?
Organogenesis Holdings Inc. (ORGO) reported accretion to redemption value and cumulative dividends on redeemable convertible preferred stock of $3M in Q1 2026.
How has Organogenesis Holdings Inc.'s accretion to redemption value and cumulative dividends on redeemable convertible preferred stock changed year-over-year?
Organogenesis Holdings Inc.'s accretion to redemption value and cumulative dividends on redeemable convertible preferred stock increased by 9.3% year-over-year, from $2.75M to $3M.
What does accretion to redemption value and cumulative dividends on redeemable convertible preferred stock mean?
This represents the periodic increase in the carrying value of redeemable preferred stock due to dividend accruals or adjustments toward the redemption price. It functions as a non-cash charge that impacts the earnings available to common shareholders. Investors use this to evaluate the true cost of capital associated with preferred equity structures.